LONDON/NEW YORK (Reuters) -Drugmakers are lobbying U.S. President Donald Trump to phase in tariffs on imported pharmaceutical ...

The pharmaceutical sector is a huge part of the Irish economy, providing thousands of well-paid jobs and contributing ...

Jerome Stevens Pharmaceuticals, Inc., a US-based prescription pharmaceutical manufacturer and packager, has completed the ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Drugmakers are lobbying US president Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time to shift manufacturing, ...

Pharmaceutical warehousing is not just about storing products; it’s a critical part of the supply chain that ensures the ...

The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to ...

KKR, the U.S.-based private equity giant, has divested a 5.8 per cent stake in JB Chemicals & Pharmaceuticals for Rs 1,460 ...

Sources said the offer price was set at ₹1,625 per share, a 4.9% discount to its last closing price. The total deal size was ...

ISLAMABAD: The Drug Regulatory Authority Pakistan (DRAP) has issued an immediate recall alert for a number of substandard ...